NCT04633863View on ClinicalTrials.gov

Study on Safety and Performance of an Artificial Tear in Dry Eye Treatment in Subjects With Ocular Surface Inflammation

NACompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

October 12, 2020

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions

Dry Eye Disease

Interventions

DEVICE

Artificial tear MDI - 101

Medical device CE marked - artificial tears containing arabinogalactan, trehalose and hyaluronic acid - 10 weeks treatment

Trial Locations (1)

Unknown

Ophthalmology unit, Lucca

Sponsors

Collaborators (1)

Hippocrates Research

All Listed Sponsors

collaborator

Hippocrates Research

OTHER

collaborator

Nubilaria Srl

UNKNOWN

lead

MD Italy

INDUSTRY

NCT04633863 - Study on Safety and Performance of an Artificial Tear in Dry Eye Treatment in Subjects With Ocular Surface Inflammation | Biotech Hunter | Biotech Hunter